Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis who have a history of systemic therapies: a post hoc analysis of a phase III trial

International Immunopharmacology 2026

View at publisher
Authors: Junfeng Zhou, Shanshan Li
DOI: 10.1016/j.intimp.2026.116161
Cited by: 0
References: 28

Fields of Study & Subjects

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Spondyloarthritis Studies and Treatments

Publication details

Journal / source
International Immunopharmacology
Volume
172
Pages
116161–116161
Publication date
16 January 2026
Language
EN